Many cities and countries still view the foundation of a biotech sector as desirable for a high-tech, intellectually driven economy. But a discussion by seasoned biotech management and investors suggests that attaining an environment with the right mix of money, management and innovation remains a difficult and long-term challenge.
Location is interwoven with the ability of biotech startups to prosper. Regions with
nascent biotech sectors often find attracting the necessary financial and human resources to
their area an uphill struggle, which can mean the difference between success or failure for a fledgling life science business. In the following article, a group of experienced biotech executives and investors from around the world discuss the pros and cons of building a business inside or
outside a cluster. The article is an abridged transcript of a Bioentrepreneur roundtable discussion
held at the Marriott Boston Copley Place; it was convened at the Biotechnology Industry
Organization International Convention in Boston, May 5, 2007. It has been edited to
address the major themes of that discussion.